Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 77112708 | FILING DATE | 02/21/2007 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | STINE, DAVID H |
L.O. ASSIGNED | 114 |
PUB INFORMATION |
|||
RUN DATE | 09/20/2008 | ||
PUB DATE | 08/07/2007 | ||
STATUS | 731-SECOND EXTENSION - GRANTED | ||
STATUS DATE | 09/18/2008 | ||
LITERAL MARK ELEMENT | VEVENU | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | YES | 44E | YES | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | VEVENU |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 20-OWNER AT PUBLICATION |
NAME | Glaxo Group Limited |
ADDRESS | Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex, UB60NN |
ENTITY | 03-CORPORATION |
CITIZENSHIP | United Kingdom |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Pharmaceutical preparations and substances for the treatment and/or alleviation of diseases and disorders of the central nervous system, and psychiatric related diseases and disorders |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
PRIORITY CLAIMED | N/A |
APPLICATION NO. | N/A |
APPLICATION FILING DATE | N/A |
FOREIGN REG NO. | 2361685 |
FOREIGN REG DATE | 04/23/2004 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 04/23/2014 |
FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
09/18/2008 | EX2G | S | EXTENSION 2 GRANTED | 015 |
09/18/2008 | EXT2 | S | EXTENSION 2 FILED | 014 |
09/18/2008 | EEXT | I | TEAS EXTENSION RECEIVED | 013 |
03/14/2008 | EX1G | S | EXTENSION 1 GRANTED | 012 |
02/20/2008 | EXT1 | S | EXTENSION 1 FILED | 011 |
02/20/2008 | EEXT | I | TEAS EXTENSION RECEIVED | 010 |
02/01/2008 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 009 |
10/30/2007 | NOAM | O | NOTICE OF ALLOWANCE-MAILED | 008 |
08/07/2007 | PUBO | A | PUBLISHED FOR OPPOSITION | 007 |
07/18/2007 | NPUB | O | NOTICE OF PUBLICATION | 006 |
07/03/2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 005 |
07/03/2007 | ALIE | A | ASSIGNED TO LIE | 004 |
05/30/2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 003 |
05/30/2007 | DOCK | D | ASSIGNED TO EXAMINER | 002 |
02/26/2007 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Maribeth Day Case |
CORRESPONDENCE ADDRESS | Maribeth Day Case GlaxoSmithKline MAI-B443 Five Moore Drive Research Triangle Park NC 27709 |
DOMESTIC REPRESENTATIVE | Maribeth Day Case |
PRIOR OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Glaxo Group Limited |
ADDRESS | Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex, UB60NN |
ENTITY | 03-CORPORATION |
CITIZENSHIP | United Kingdom |